Trial Profile
Open-Label, Randomized, Dose Escalation Phase I Study in Healthy Adult Volunteers to Evaluate the Safety and Pharmacokinetics of a Human Monoclonal Antibody to Rabies (SII RMab) in Comparison to Human Rabies Immune Globulin Administered in Conjunction with Rabies Vaccine (RABIVAX).
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs Anti-rabies monoclonal antibody (Primary) ; Rabies immune globulin; Rabies vaccine
- Indications Rabies
- Focus Adverse reactions
- 12 Sep 2010 Results were presented at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy.
- 11 Jul 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India.
- 09 Feb 2010 New trial record